Acticor Biotech in Les Echos journal

The full article from the French financial newspaper is available here :
Acticor Biotech agit contre l’AVC avec un anticorps monoclonal

Read next in 'Media Coverage'

• ACT017 : un fragment d’anticorps dont l’ACTion antithrombotique est prometteuse !
• Novel antiplatelet could circumvent bleeding risk for stroke patients
• Experimental antiplatelet compound for acute stroke shows promise
• New drug to prevent clots clears safety hurdle
• New blood thinner may prevent stroke, without risk for bleeding